← Leaderboards
Leanne Embry
Children'S Research Institute
$966,021
Attributed
$1,932,042
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $471.5K · FY2017–21$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,932,042 · 1
By mechanism
R01$1,932,042 · 1
Top collaborators
- Kristina K. Hardy4 shared
- Pamela S Hinds1 shared
Most similar at Children'S Research Institute
Same institution · by research overlap
- Catherine Mary Bollard$14,999,215
- Shayna Skelley Coburn$793,000
- Adeline Lucie Vanderver$19,932,242
- Lauren Kenworthy$8,071,804
- Debra S Regier$1,731,231
Others in their field
Other Emerging Leaders on “Acute Lymphocytic Leukemia”
- Crystal Mackall · Children'S Hosp Of Philadelphia$12,361,966
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,557,384
- Adam De Smith · University Of Southern California$5,277,579
- Karen R Rabin · Baylor College Of Medicine$4,946,686
- Ernesto Guccione · Icahn School Of Medicine At Mount Sinai$4,876,508
Research focus
Acute Lymphocytic LeukemiaAffectAftercareChildChildhoodClinical Practice GuidelineCognitiveCognitive DeficitsCognitive FunctionCognitive TestingComputerizedCostCost EffectiveDiagnosisEarly DiagnosisEarly InterventionEducationEmotional DistressEmploymentEvaluationEventEvidence BaseFamilyAccounting
Grant awards (5)
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment$370,393
R01 · FY2021 · CA
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment$363,865
R01 · FY2020 · CA
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment$352,062
R01 · FY2019 · CA
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment$374,232
R01 · FY2018 · CA
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment$471,490
R01 · FY2017 · CA